-+ 0.00%
-+ 0.00%
-+ 0.00%

CATALYST PHARMACEUTICALS ANNOUNCES HEALTH CANADA’S ACCEPTANCE OF AGAMREE® NEW DRUG SUBMISSION WITH PRIORITY REVIEW FOR SUB-LICENSEE KYE PHARMACEUTICALS

Reuters·04/08/2025 12:06:43

Please log in to view news